Quinazoline derivatives as inhibitors of VEGF receptor tyrosine kinases

Details for Australian Patent Application No. 2004262982 (hide)

Owner AstraZeneca AB

Inventors Hennequin, Laurent Francois Andre

Agent Davies Collison Cave

Pub. Number AU-A-2004262982

PCT Pub. Number WO2005/013998

Priority 0318423.1 06.08.03 GB

Filing date 5 August 2004

Wipo publication date 17 February 2005

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/013998 Priority application(s): WO2005/013998

19 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262985-Coating of surgical devices

2004262980-Antigen delivery system